Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 30:13:977819.
doi: 10.3389/fendo.2022.977819. eCollection 2022.

Cardiovascular disease risk in offspring of polycystic ovary syndrome

Affiliations
Review

Cardiovascular disease risk in offspring of polycystic ovary syndrome

Noha M Shawky. Front Endocrinol (Lausanne). .

Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder affecting women at reproductive age. PCOS diagnosis (Rotterdam criteria) is based on the presence of two out of three criteria; clinical and/or biochemical hyperandrogenism, oligo- or an-ovulation and polycystic ovaries. PCOS women suffer from a constellation of reproductive and metabolic abnormalities including obesity and insulin resistance. PCOS women also have increased blood pressure and increased risk of cardiovascular diseases (CVD). In-utero, offspring of PCOS women are exposed to altered maternal hormonal environment and maternal obesity (for most of PCOS women). Offspring of PCOS women could also be subject to genetic susceptibility, the transgenerational transmission of some of the PCOS traits or epigenetic changes. Offspring of PCOS women are commonly reported to have an abnormal birth weight, which is also a risk factor for developing CVD and hypertension later in life. Although studies have focused on the growth pattern, reproductive and metabolic health of children of PCOS women, very limited number of studies have addressed the risk of hypertension and CVD in those offspring particularly as they age. The current narrative review is designed to summarize the available literature (both human studies and experimental animal studies) and highlight the gaps in addressing hypertension and CVD risks in offspring of PCOS women or hyperandrogenemic female animal models.

Keywords: cardiovascular disease; hypertension; offspring; polycystic ovary syndrome; sex differences.

PubMed Disclaimer

Conflict of interest statement

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Rationale and possible mechanisms behind increased risk of hypertension (HTN) and other cardiovascular diseases (CVD) in offspring of polycystic ovary syndrome (PCOS) women. BMI, body mass index; HA, hyperandrogenism; OA, oligo- or an-ovulation; PCOM, polycystic ovarian morphology; GDM, gestational diabetes mellitus; PIH, pregnancy-induced hypertension; PE, pre-eclampsia; LGA, large-for-gestational age; SGA, small-for-gestational age.

References

    1. Azziz R. Polycystic ovary syndrome. Obstetrics Gynecology (2018) 132(2):321–36. doi: 10.1097/AOG.0000000000002698 - DOI - PubMed
    1. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group . Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod (2004) 19(1):41–7. doi: 10.1093/humrep/deh098 - DOI - PubMed
    1. Gibson-Helm M, Teede H, Dunaif A, Dokras A. Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2017) 102(2):604–12. doi: 10.1210/jc.2016-2963 - DOI - PMC - PubMed
    1. Holte J, Gennarelli G, Berne C, Bergh T, Lithell H. Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state? Hum Reprod (Oxford England) (1996) 11(1):23–8. doi: 10.1093/oxfordjournals.humrep.a019028 - DOI - PubMed
    1. Reckelhoff JF, Shawky NM, Romero DG, Yanes Cardozo LL. Polycystic ovary syndrome: Insights from pre-clinical research. Kidney (2022) 3(8):1449–57. doi: 10.34067/KID.0002052022 - DOI - PMC - PubMed

Publication types

LinkOut - more resources